EFPIA is delighted to announce that Lisa Latts, Deputy Chief Health Officer for Value Based Care, IBM Watson Health, will be speaking in the panel "Data: unlocking tomorrow’s cures – shaping tomorrow’s care", at our Annual Conference.

Watson Health aspires to improve lives and give hope by delivering innovation to address the world’s most pressing health challenges through data and cognitive insights. Dr. Latts will discuss how we are leveraging data and advanced analytics to advance more rapid and efficient delivery of targeted and effective therapies. From enabling life science researchers to discover new drug targets and alternative drug indications to supporting efforts to maintain patient safety and availability of critical drugs, cognitive computing can transform healthcare.

Eduardo Bravo (President of EBE, the specialised group of EFPIA for biopharmaceuticals & CEO, TiGenix) will highlight the crucial role of small and medium-sized enterprises in developing innovative medicines for tomorrow.

Leading the comparatively-small but growing company that achieved the first European authorisation for an advanced therapy medicinal product, Eduardo will give a first-hand report of the critical importance of incentives to the successful development of innovative medicines in Europe